- No more than 6 discrete active extracranial lesions (≤ 3 in the liver and ≤ 3 in the lung) identified by positron emission tomography (PET) and by correlative plain film, CT scan, or MRI within 8 weeks prior to the initiation of stereotactic body radiotherapy (SBRT)